Advancing targeted radionuclide therapy in nuclear medicine – A future perspective
EANM Innovation · 2025
DOI: 10.1016/j.eanmi.2025.100007 ↗Kurz gefasst
Fachartikel in der Zeitschrift EANM Innovation, 2025. Verfasst von Govert de With und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, H2020 Euratom.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Horizon 2020 Framework Programme
- H2020 Euratom
Zitieren
APA
With, G. D., Tinsley, T., Mikolajczak, R., Schram, R., Visvikis, D., Boix, C., Pavel, G. L., Capogni, M., Baatout, S., & Bidakhvidi, N. A. (2025). Advancing targeted radionuclide therapy in nuclear medicine – A future perspective. EANM Innovation. https://doi.org/10.1016/j.eanmi.2025.100007
Vancouver
With GD, Tinsley T, Mikolajczak R, Schram R, Visvikis D, Boix C, et al. Advancing targeted radionuclide therapy in nuclear medicine – A future perspective. EANM Innovation. 2025. doi:10.1016/j.eanmi.2025.100007
BibTeX
@article{With2025,
author = {With, Govert de and Tinsley, Tim and Mikolajczak, Renata and Schram, Ronald and Visvikis, Dimitris and Boix, Camila and Pavel, Gabriel Lazaro and Capogni, Marco and Baatout, Sarah and Bidakhvidi, Niloefar Ahmadi},
title = {Advancing targeted radionuclide therapy in nuclear medicine – A future perspective},
journal = {EANM Innovation},
year = {2025},
doi = {10.1016/j.eanmi.2025.100007}
}
EUVIMED